IBBiShares Nasdaq Biotechnology ETF(Exchange Traded Fund )
XTF Rating* 8.2
Price:$332.75 2.79(0.85%)
52 Week:$246.71 - $336.72
Volume: 718,703
Avg Daily Volume: 1,027,185
Market Cap: $9,717,322,000 Avg Trade Size: 94 shares
Fund Turnover: 31 days 9/20/2017 4:00:00 PM
Similar ETFs to IBB: ARKG, LNGR, SBIO, CNCR, IXJ

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2/5/2001Geography: Global  Asset Class: Equity
Primary Exchange: NASDAQ Stock MarketInvestment Philosophy: Passively ManagedCapitalization: Broad/Multi Cap
Issuer: BlackRock, Inc.Underlying Index: NASDAQ Biotechnology IndexSector: Healthcare > Biotechnology
Index Provider: NASDAQ OMX Group, Inc.Index Composition: Cap-Weighted

Structural Integrity
Investment Metrics
Fund Holdings
Fund Exposure
News Headlines
IBB Structural Integrity ranks in the 81st percentile (among all 1363 Equity ETFs over past 6 months).
as of 8/1/2017 Value  Rank (%)
Expense Ratio 0.47% 
 41.4%
Average Bid Ask Ratio Premium Content 
 82%
Tracking Error Premium Content 
 96.2%
Concentration Risk Premium Content 
 16.1%
Market Impact Premium Content 
 93.4%
Efficiency Premium Content 
 51.3%
Cap Gains Dist Premium Content 
 100%
     
as of 9/19/2017  
Avg Number of Components   (range) 162   (161-163)
Legal Structure Open-End Investment Company 
Annual Yield / SEC Yield 0.2% / -0.02%
Last Dividend PaidDate 0.18, 6/27/2017   See Distributions
Options / Futures Available Y  /  Y 
Short Interest / Days to Cover 14.6% /  4 days
Net Asset Value $9,720,550,866 
Premium (Discount) -0.03% 
*The XTF Rating for an ETF is based on statistical analysis of its structural integrity and investment metric giving a total range between 0 and 10 with 10 being the best. Read More.





© LSEG Information Services (US) Inc., All Rights Reserved. Disclaimer. Terms of Use. Privacy Policy. .59